Advertisement
Skip to Content

RenovaCare Inc RCAR Stock Quote

| Rating as of

PINX: RCAR

Last close prices updated as of Feb 03, 2023, 3:58 PM EST | USD
  • Last Close 0.145
  • Sector Healthcare
  • Industry Biotechnology
  • Investment Style
  • Day Range 0.08  –  0.18
  • Year Range 0.01  –  0.36
  • Market Cap 12.6661 Mil
  • Volume / Avg 88,229.0 /  33,144.4
  • Price / Sales
  • Price / Book 5.11
  • Forward Div Yield 3.97%
  • Trailing Div Yield

Morningstar‘s Stock Analysis RCAR

Valuation
Currency in
Is it the right time to buy or sell?
Is it the right time to buy or sell?

1-Star Price

INVESTOR

5-Star Price

INVESTOR

Economic Moat

INVESTOR

About Quantitative Ratings

Morningstar Quantitative ratings for equities (denoted on this page by) are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies withratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating. Click here for more on how to use these ratings.

Unlock Our Full Analysis With Morningstar Investor

Key Statistics RCAR

Company Profile RCAR

Business Description

RenovaCare Inc is a biotechnology company focusing on the acquisition, research, development and commercialization of autologous cellular therapies that can be used for medical and aesthetic applications. The company's initial products under development target skin. It offers treatment methodology for cell isolation for the regeneration of human skin cells, along with a medical-grade liquid spraying device and associated equipment (the SkinGun). RenovaCare is evaluating the efficacy and potential of SkinGun, in combination with a cell isolation method, in the treatment of tissue that has been subject to severe trauma. Geographically all the activities are functioned through the region of United States.

Contact
9375 East Shea Boulvard, Suite 107-A
Scottsdale, AZ, 85260
Industry Biotechnology
Employees 1

FAQs for RenovaCare Inc Stock

Yes. RCAR has a forward dividend yield of 3.97%. See RCAR’s full dividends and stock split history on the Dividend tab.
Dividend yield allows investors, particularly those interested in dividend-paying stocks, to compare the relationship between a stock’s price and how it rewards stockholders through dividends. The formula for calculating dividend yield is to divide the annual dividend paid per share by the stock price.

Learn more about dividend yield.

RCAR’s market cap is 12.67 Mil.
Market capitalization is calculated by taking a company’s share price and multiplying it by the total number of shares. It’s often used to measure a company’s size. In the Morningstar Style Box, large-cap names account for the largest 70% of U.S. stocks, mid-cap names account for the largest 70–90%, and small-cap names are the remaining 10% of companies.

Learn more about market capitalization.

RCAR’s beta can be found in Trading Information at the top of this page.
A stock’s beta measures how closely tied its price movements have been to the performance of the overall market.

Compare RCAR’s historical performance against its industry peers and the overall market.